Literature DB >> 23410730

The long-term psychosocial impact of corrective surgery for adults with strabismus.

Sue Jackson1, Marianne Morris, Kathryn Gleeson.   

Abstract

BACKGROUND/AIM: Long-term assessments of the impact of strabismus surgery in adults are rare and very limited in focus. Consequently, this study was designed to consider the psychosocial status of adults a minimum of 1 year after surgery.
METHODS: A repeated measures design, 25 participants were seen at 6-week pre-operative (T1), 3-month (T2) and 18-month (T3) post-operative appointments. Participants completed a battery of psychological scales comprising: Hospital Anxiety and Depression scale, the World Health Organisation Quality of Life assessment (short form), the Derriford Appearance Scale, and visual analogue scales to measure the impact of strabismus and its treatment on psychological adjustment and daily functioning.
RESULTS: At T2, all scores on all study measures had significantly improved. At T3, some study measures were showing continued improvement: World Health Organisation Quality of Life Assessment - short form (WHOQoL-Bref) social and environment domains; DAS-24; VAS scales for coping, postoperative satisfaction, strabismus noticeability and strabismus severity. A one-way Analysis of Variance (ANOVA) showed significant effects across time for DAS-24 and all VAS scales. Post hoc tests indicated that significant changes occurred between T1 and T2 and between T1 and T3.
CONCLUSIONS: This study suggests that adjustment is a long-term process with improvements on some study measures being greater at 18 months than at 3 months postoperatively raising the possibility that some psychosocial goals are more appropriately measured in the longer term.

Entities:  

Mesh:

Year:  2013        PMID: 23410730     DOI: 10.1136/bjophthalmol-2012-302983

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

Review 1.  We need to pay heed to the psychosocial aspects of strabismus.

Authors:  I B Marsh
Journal:  Eye (Lond)       Date:  2014-12-05       Impact factor: 3.775

2.  Does strabismus surgery improve quality and mood, and what factors influence this?

Authors:  H B McBain; K A MacKenzie; J Hancox; D G Ezra; G G W Adams; S P Newman
Journal:  Eye (Lond)       Date:  2016-04-29       Impact factor: 3.775

3.  Gain beyond cosmesis: demonstration of psychosocial and functional gains following successful strabismus surgery using the adult strabismus questionnaire adult strabismus 20.

Authors:  Danish Alam; Adeeb Alam Khan; Sadat Ao Bani; Richa Sharma; Abadan K Amitava
Journal:  Indian J Ophthalmol       Date:  2014-07       Impact factor: 1.848

4.  Difference of Self-identity Levels between Strabismus Patients and Normal Controls.

Authors:  Youngjun Kim; Cheron Kim; Seongjae Kim; Yongseop Han; Inyoung Chung; Seongwook Seo; Jongmoon Park; Jimyong Yoo
Journal:  Korean J Ophthalmol       Date:  2016-12-06

5.  Long-Term Quality of Life in Adult Patients with Strabismus after Corrective Surgery Compared to the General Population.

Authors:  Meiping Xu; Huanyun Yu; Yuanyuan Chen; Jinling Xu; Jingwei Zheng; Xinping Yu
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

6.  School-based assessment of amblyopia and strabismus among multiethnic children in rural China.

Authors:  Chen-Wei Pan; Xuejuan Chen; Hui Zhu; Zhujun Fu; Hua Zhong; Jun Li; Dan Huang; Hu Liu
Journal:  Sci Rep       Date:  2017-10-17       Impact factor: 4.379

7.  Development of a conceptual model regarding quality of life in Chinese adult patients with strabismus: a mixed method.

Authors:  Zonghua Wang; Juan Zhou; Yan Xu; Honghua Yin; Xi She; Wei Bian; Xianyuan Wang
Journal:  Health Qual Life Outcomes       Date:  2018-09-03       Impact factor: 3.186

8.  To assess knowledge and attitude of parents toward children suffering from strabismus in Indian subcontinent.

Authors:  Anirudh Singh; Vipin Rana; Sagarika Patyal; Santosh Kumar; Sanjay K Mishra; Vijay K Sharma
Journal:  Indian J Ophthalmol       Date:  2017-07       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.